Telix Pharmaceuticals has announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the ...

Revolutionary AI breast cancer screening trial launches across 30 UK sites, promising to tackle radiologist shortages and speed up diagnosis for 700,000 women.

Almost 700,000 women are expected to take part in a trial, with some 30 testing sites across the country being enhanced with ...

AI tools like the ones being tested in the EDITH trial could help facilitate the screening process, allowing the NHS to ...

At the moment mammograms require the expertise of two radiologists ... Breast cancer is the most common cancer diagnosed in women in the UK, with around 55,000 diagnoses a year.